Drugs / CNSI-Fe
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07433283 | Nov 2024 → Dec 2026 expected | cervical cancer, colorectal cancer, lung cancer, malignant pancreatic neoplasm +3 | Sichuan Enray Pharmaceutical Sciences Company | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CNSI-Fe | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07433283 ↗ |
| Known as | Carbon Nanoparticle-Loaded Iron | “Carbon Nanoparticle-Loaded Iron [CNSI-Fe]” NCT07433283 ↗ |
| Route | Other | “CNSI-Fe intratumoral injection” NCT07433283 ↗ |